May 15, 2019

Powles T et al. Nature Medicine 2019;25:1706–1714.

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial

Access publication

You might also be interested by

Brochures

Immunohistochemistry (IHC) Biomarker List

November 10, 2021

Histopathology

More info

Brochures

Cell Therapy

November 5, 2021

Histopathology

More info

Brochures

Oncology & Immuno-Oncology Expertise

November 5, 2021

Histopathology

More info